SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Comment Letter for XOMA Royalty Holdings Corp (CIK 0002135883) — Jun 2, 2026

XOMA Royalty Holdings Corp (CIK 0002135883)
Date: June 2, 2026 · CIK: 0002135883 · Accession: 0000000000-26-005557

AI Filing Summary & Sentiment

File numbers found in text: 333-296211

Date
June 2, 2026
Author
Not clearly detected
Form
UPLOAD
Company
XOMA Royalty Holdings Corp (CIK 0002135883)

Letter

June 2, 2026 Owen Hughes President, Secretary and Treasurer XOMA Royalty Holdings Corporation 2200 Powell Street, Suite 310 Emeryville, CA 94608 Re: XOMA Royalty Holdings Corporation Registration Statement on Form S-4 Filed May 26, 2026 File No. 333-296211 Dear Owen Hughes: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at 202-551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Branden C. Berns, Esq.

Show Raw Text
June 2, 2026
Owen Hughes
President, Secretary and Treasurer
XOMA Royalty Holdings Corporation
2200 Powell Street, Suite 310
Emeryville, CA 94608
Re: XOMA Royalty Holdings Corporation
Registration Statement on Form S-4
Filed May 26, 2026
File No. 333-296211
Dear Owen Hughes:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Tim Buchmiller at 202-551-3635 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Branden C. Berns, Esq.